Dose-independent antinociceptive interaction of endogenous ligands at the spinal level

Brain Research

Volumn 1029, Issue 1, 2004, Pages 93-102

  Kekesi, Gabriella ^a   Joo, Gabriella ^a   Csullog, Emese ^a,b   Peter Szabo, Mihaly ^c   Benedek, Gyorgy ^a   Horvath, Gyongyi ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c NONE

Author keywords

2 Adrenoceptor; Adenosine; Agmatine; Imidazoline; Kynurenic acid; NMDA receptor

Indexed keywords

ADENOSINE; AGMATINE; CARRAGEENAN; KYNURENIC ACID;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; HUMAN; HYPERACTIVITY; HYPERALGESIA; MOTOR DYSFUNCTION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ADENOSINE; AGMATINE; ANALGESICS; ANIMALS; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; HYPERALGESIA; INJECTIONS, SPINAL; KYNURENIC ACID; LIGANDS; MALE; PAIN THRESHOLD; RATS; RATS, WISTAR; REACTION TIME;

EID: 7744221430     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.09.039     Document Type: Article

References (65)

1. K.O. Aley, G. McCarter, and J.D. Levine Nitric oxide signaling in pain and nociceptor sensitization in the rat J. Neurosci. 18 1998 7008 7014
2. 2 noradrenergic agonist and 5′-N-ethylcarboxamide adenosine Brain Res. 519 1990 287 293
3. S. Aran, and H.K. Proudfit Antinociception produced by interactions between intrathecally administered adenosine agonists and norepinephrine Brain Res. 513 1990 255 263
4. M. Auguet, I. Viossat, J.-G. Marin, and P.-E. Chabrier Selective inhibition of inducible nitric oxide synthase by agmatine Jpn. J. Pharmacol. 69 1995 285 287
5. A.K. Baker, V.L. Hoffmann, and T.F. Meert Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay Acta Anaesthesiol. Belg. 53 2002 203 212
6. C. Bradley Dexmedetomidine-a novel sedative for postoperative sedation Intensive Crit. Care Nurs. 16 2000 328 329
7. 2-adrenoceptor or μ-opioid receptor mechanisms Eur. J. Pharmacol. 331 1997 133 138
8. R. Carpenedo, A. Pittaluga, A. Cozzi, S. Attucci, A. Galli, M. Raiteri, and F. Moroni Presynaptic kynurenate-sensitive receptors inhibit glutamate release Eur. J. Neurosci. 13 2001 2141 2147
9. V. Chapman, and A.H. Dickenson Time related roles of excitatory amino acid receptors during persistent noxiously evoked responses of rat dorsal horn neurones Brain Res. 703 1995 45 50
10. A. Chiari, and J.C. Eisenach Intrathecal adenosine: interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity Anesthesiology 90 1999 1413 1421
11. A. Chiari, T.L. Yaksh, R.R. Myers, J. Provencher, L. Moore, C.-S. Lee, and J.C. Eisenach Preclinical toxicity screening of intrathecal adenosine in rats and dogs Anesthesiology 91 1999 824 832
12. T.J. Coderre, and I.V. Empel The utility of excitatory amino acid (EAA) antagonists as analgesic agents: I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests Pain 59 1994 345 352
13. E. Csullog, G. Joo, G. Toth, I. Dobos, G. Benedek, and G. Horvath Antinociceptive effect of continuous intrathecal administration of endomorphin-1 Pain 94 2001 31 38
14. V. Dahl, and J.C. Raeder Non-opioid postoperative analgesia Acta Anaesthesiol. Scand. 44 2000 1191 1203
15. G.E. DeLander, and J.J. Wahl Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally J. Pharmacol. Exp. Ther. 246 1988 565 570
16. J. Desmeules, V. Rollason, V. Piguet, and P. Dayer Clinical pharmacology and rationale of analgesic combinations Eur. J. Anaesthesiol. 20 2003 7 12
17. I. Dobos, K. Toth, G. Kekesi, G. Joo, E. Csullog, W. Klimscha, G. Benedek, and G. Horvath The significance of intrathecal catheter location in rats Anesth. Analg. 96 2003 487 492
18. 2-Adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984-1995) Anesthesiology 85 1996 655 674
19. J.C. Eisenach, D.D. Hood, and R. Curry Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans Anesthesiology 96 2002 29 34
20. 2 adrenoceptor agonists on the in vitro rat spinal cord preparation Br. J. Pharmacol. 124 1998 507 512
21. G.B. Glavin, M.A. Carlisle, and D.D. Smyth Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosl injury in rats J. Pharmacol. Exp. Ther. 274 1995 741 744
22. J.A. Gomes, X. Li, H.-L. Pan, and J.C. Eisenach Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats Anesthesiology 91 1999 1072 1079
23. H.A. Hager, P. Marhofer, C. Sitzwohl, L. Adler, S. Kettner, and M. Semsroth Caudal clonidine prolongs analgesia from caudal S(+)-ketamine in children Anesth. Analg. 94 5 2002 1169 1172
24. K. Hargreaves, R. Dubner, F. Brown, C. Flores, and J. Joris A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia Pain 32 1988 77 88
25. G.A. Head, C.K.S. Chan, and S.J. Godwin Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits Neurochem. Res. 30 1997 37 45
26. C. Hilmas, E.F. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E.X. Albuquerque The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J. Neurosci. 12 2001 7463 7473
27. G. Horvath, W. Klimscha, I. Dobos, M. Szikszay, G. Benedek, and J.C. Eisenach Intrathecal agmatine pretreatment decreases the hyperalgesia and potentiates the morphine induced antinociception in rats Reg. Anesth. 9 1997 67
28. G. Horvath, G. Kekesi, I. Dobos, M. Szikszay, W. Klimscha, and G. Benedek Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats Eur. J. Pharmacol. 368 1999 197 204
29. +-ATPase using in vitro and in vivo studies Eur. J. Pharmacol. 458 2003 291 297
30. V. Jevtovic-Todorovic, D.F. Wozniak, S. Powell, A. Nardi, and J.W. Olney Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects Brain Res. 781 1998 202 211
31. G. Joo, G. Horvath, W. Klimscha, G. Kekesi, I. Dobos, M. Szikszay, and G. Benedek The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats Anesthesiology 93 2000 231 241
32. G. Kekesi, G. Joo, E. Csullog, I. Dobos, W. Klimscha, K. Toth, G. Benedek, and G. Horvath The antinociceptive effect of intrathecal kynurenic acid and its interaction with endomorphin-1 in rats Eur. J. Pharmacol. 445 2002 93 96
33. G. Kekesi, I. Dobos, G. Benedek, and G. Horvath The antinociceptive potencies and interactions of endogenous ligands during continuous intrathecal administration: adenosine, agmatine, and endomorphin-1 Anesth. Analg. 98 2 2004 420 426
34. I.M. Khan, P. Taylor, and T.L. Yaksh Stimulatory pathways and sites of action of intrathecally administered nicotinic agents J. Pharmacol. Exp. Ther. 271 1994 1550 1557
35. P. Lavand'homme, and J.C. Eisenach Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain Pain 80 1999 31 36
36. Y.-W. Lee, and T.L. Yaksh Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model Anesthesiology 82 1995 741 748
37. 2A-Adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes J. Pharmacol. Exp. Ther. 299 2001 939 944
38. J.A. Mastrianni, and A.J. Ingenito Acute tolerance to clonidine hypotension and bradycardia in normotensive and hypertensive rats Pharmacol. Res. Commun. 17 1985 865 872
39. H. Nagaoka, S. Sakurada, T. Sakurada, S. Takeda, Y. Nakagawa, K. Kisara, and Y. Arai Theophylline-induced nociceptive behavioral response in mice: possible indirect interaction with spinal N-methyl-d-aspartate receptors Neurochem. Int. 22 1993 69 74
40. J. Näsström, U. Karlsson, and C. Post Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice Eur. J. Pharmacol. 212 1992 21 29
41. M.-R. Nikbakht, and T.W. Stone Suppression of presynaptic responses to adenosine by activation of NMDA receptors Eur. J. Pharmacol. 427 2001 13 25
42. T. Nishiyama, L. Gyermek, C. Lee, S. Kawasaki-Yatsugi, T. Yamaguchi, and K. Hanaoka The analgesic interaction between intrathecal clonidine and glutamate receptor antagonists on thermal and formalin-induced pain in rats Anesth. Analg. 92 3 2001 725 732
43. G.H.M. Paalzow Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats Eur. J. Pharmacol. 252 1994 87 97
44. I. Power, and S. Barratt Analgesic agents for the postoperative period. Nonopioids Surg. Clin. North Am. 79 1999 275 295
45. 2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeinte exposure J. Neurochem. 88 2004 1151 1158
46. W. Raasch, U. Schäfer, J. Chum, and P. Dominiak Biological significance of agmatine, an endogenous ligand at imidazoline binding sites Br. J. Pharmacol. 133 2001 755 780
47. G. Raigorodsky, and G. Urca Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualat modulates the action of N-methyl-d-aspartate Eur. J. Pharmacol. 182 1990 37 47
48. K. Rane, M. Segerdahl, M. Goiny, and A. Sollevi Intrathecal adenosine administration. A phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain Anesthesiology 89 1998 1108 1115
49. D.J. Reis, and S. Regunathan Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain J. Auton. Nerv. Syst. 72 1998 80 85
50. K. Ren, G.M. Williams, J.L.K. Hylden, M.A. Ruda, and R. Dubner The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats Eur. J. Pharmacol. 219 1992 235 243
51. A. Sandner-Kiesling, X. Li, and J.C. Eisenach Morphine-induced spinal release of adenosine is reduced in neuropathic rats Anesthesiology 95 2001 1455 1459
52. J. Sawynok Adenosine receptor activation and nociception Eur. J. Pharmacol. 347 1998 1 11
53. J. Sawynok, M.I. Sweeney, and T.D. White Adenosine release may mediate spinal analgesia by morphine Trends Pharmacol. Sci. 10 1989 186 189
54. M. Segerdahl, A. Ekblom, and A. Sollevi The influence of adenosine, ketamin, and morphine on experimentally induced ischemic pain in healthy volunteers Anesth. Analg. 79 1994 787 791
55. B. Sjölund, A. Sollevi, M. Segerdahl, and T. Lundeberg Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats Anesth. Analg. 85 1997 627 632
56. M. Sosnowski, and T.L. Yaksh Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism Anesth. Analg. 69 1989 587 592
57. S.N. Thorat, and S.K. Kulkarni Effect of MK-801 and its interaction with adenosinergic agents and carbamazepine against hypoxic stress-induced convulsions and death in mice Methods Find. Exp. Clin. Pharmacol. 12 1990 595 600
58. M. Vincler, and J.C. Eisenach Plasticity of spinal nicotinic acetylcholine receptors following spinal nerve ligation Neurosci. Res. 48 2004 139 145
59. 3H]noradrenaline release in rabbit brain cortex slices Br. J. Pharmacol. 110 1993 1544 1550
60. P.M.C. Wright, U.A. Carabine, S. McClune, D.A. Orr, and J. Moore Preanaesthetic medication with clonidine Br. J. Anaesth. 65 1990 628 632
61. T.L. Yaksh Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists Pain 37 1989 111 123
62. T.L. Yaksh, and T.A. Rudy Chronic catheterization of the spinal subarachnoid space Physiol. Behav. 17 1976 1031 1036
63. T. Yamamoto, N. Shimoyama, and T. Mizuguchi The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK-1 antagonist, on the hyperesthesia evoked by carageenan injection in the rat paw Anesthesiology 78 1993 124 133
64. T. Yamamoto, and T.L. Yaksh Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists Pain 49 1992 121 128
65. X.C. Yang, and D.J. Reis Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons J. Pharmacol. Exp. Ther. 288 1999 544 549